Hubro Therapeutics is please to announce that the application for the tax refund scheme SkatteFUNN is approved. SkatteFUNN is a Norwegian governmental initiative for startups, reducing their tax load in the initial years.
Approved SkatteFUNN provides the company with a tax refund of up to 4.75 MNOK per year (total up to 14.25 mill over the 3 year period) 2022 – 2025.